Pilot Study of a Novel First-Line Protocol (THOP) for Intermediate–Large B-Cell Lymphoma in Dogs
The current standard of care for treatment of intermediate–large B-cell lymphoma in dogs is a CHOP-based chemotherapy protocol. On-protocol disease progression is reported to be temporally associated with cyclophosphamide administration. The objectives of this prospective pilot clinical trial were t...
Saved in:
| Main Authors: | Alejandra Tellez Silva, Ester Yang, Marlie Nightengale, Nikolaos Dervisis, Shawna Klahn |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-03-01
|
| Series: | Veterinary Sciences |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2306-7381/12/3/251 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of the Efficacy of 15- and 19-Week Chemotherapy Protocols Based on Vincristine, L-Asparaginase, Doxorubicin, and Prednisolone for Dogs with Multicentric Lymphoma
by: Yi-Chen Lin, et al.
Published: (2025-02-01) -
PARP inhibitor olaparib induces DNA damage and acts as a drug sensitizer in an in vitro model of canine hematopoietic cancer
by: Jayson Cagadas Pasaol, et al.
Published: (2025-07-01) -
Characterization of the genomic landscape of canine diffuse large B-cell lymphoma reveals recurrent H3K27M mutations linked to progression-free survival
by: Anna Darlene van der Heiden, et al.
Published: (2025-02-01) -
Safety, Efficacy and Doxorubicin Pharmacokinetics During Cannabidiol/Cannabidiolic Acid Rich Hemp Oil Use in Dogs With Lymphoma Undergoing CHOP Chemotherapy
by: Amandine Lejeune, et al.
Published: (2025-07-01) -
Neurolymphomatosis of T‐Cell Origin in a Dog
by: Marie‐Kerstin Müller, et al.
Published: (2025-07-01)